Key result
3f Enable sutureless bioprosthesis maintains stable aortic gradients over 5 years with no deaths.
Why the study?
Although early clinical and hemodynamic outcomes of sutureless aortic valve replacement have been reported, few long-term follow-up results are available.
Does the Enable sutureless bioprosthesis provide stable long-term hemodynamic outcomes in patients with aortic stenosis?
Observational (n=27)
No
Does the Enable sutureless bioprosthesis provide stable long-term hemodynamic outcomes in patients with aortic stenosis?
The Enable sutureless bioprosthesis demonstrates a stable and favorable echocardiographic hemodynamic profile up to 5 years post-implantation.
No takes yet. Share an insight, caveat, or question.
Supports hemodynamic stability of the 3f Enable valve at 5 years in one case; hypothesis-generating and requires prospective validation before practice change.
Filip et al. (2018) conducted an observational in Aortic stenosis (n=27). 3f Enable sutureless bioprosthesis was evaluated on Peak and mean aortic gradients at 5 years. The 3f Enable sutureless bioprosthesis demonstrated a stable hemodynamic profile over 5 years, maintaining peak and mean aortic gradients of 16.7 mmHg and 8.9 mmHg, respectively, with no deaths.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: